MedPath

Communicating About Choices in Transplantation

Not Applicable
Completed
Conditions
End Stage Renal Disease and Kidney Transplantation
Interventions
Behavioral: COACH Program
Registration Number
NCT01853007
Lead Sponsor
Virginia Commonwealth University
Brief Summary

The purpose of this study is to test the impact of a newly developed educational program on kidney transplant candidates' communication about living and deceased donor kidney transplantation.

Detailed Description

The Communicating about Choices (COACH) in Transplantation program educates patients with end stage renal disease, who are waitlisted for kidney transplantation, about kidney disease and the risks, benefits and processes for both living and deceased donor transplantation. The program also teaches key communication skills needed to effectively initiate and manage conversations about transplantation.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Wait listed for kidney transplantation in active status
  • Adult (at least 18 years of age)
  • English speaking
  • Capable of making medical decisions (i.e., not cognitively impaired)
  • Non-institutionalized
Exclusion Criteria
  • Not listed for kidney transplantation

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
COACH ProgramCOACH ProgramParticipants randomized to the intervention condition will attend a COACH session held in a small group format. The session provides information on living and deceased donor transplantation (i.e., the processes, risks and benefits) and on the key communication skills needed to effectively initiate and maintain conversations about transplantation.
Primary Outcome Measures
NameTimeMethod
Change in engagement in discussion of living and deceased donor transplantationBaseline (upon enrollment); 1 month post; 3 months post

2 self-report items: whether transplantation was discussed (yes/no) and the number of discussions held

Change in knowledge of living and deceased donor transplantUpon enrollment (baseline); 1 month post; 2 months post

15 True/False Questions

Secondary Outcome Measures
NameTimeMethod
Change in intentions to discuss living and deceased donor transplantationUpon enrollment (baseline); 1 month post; 3 months post

3-item, 7-point Likert-type scale

Trial Locations

Locations (1)

Virginia Commonwealth University

🇺🇸

Richmond, Virginia, United States

© Copyright 2025. All Rights Reserved by MedPath